Immune checkpoint inhibitors influence the recognition of cancer cells by T cells [35,36], and VEGF inhibitors influence the infiltration of T cells into tumors [37,38] and the reduction in myeloid-derived suppressor cells and Tregs [39,40,41] in the cancer-immunity cycle [42]. This evidence concerns the gene VEGFA and cancer.